These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24618936)

  • 21. Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children.
    Levin MJ; Anderson JP; Seage GR; Williams PL;
    J Acquir Immune Defic Syndr; 2009 Feb; 50(2):182-91. PubMed ID: 19131890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous cryptococcosis as a rare manifestation of the immune reconstitution syndrome in an HIV-1-infected patient.
    Gasiorowski J; Knysz B; Szetela B; Gładysz A
    Postepy Hig Med Dosw (Online); 2008 Jan; 62():1-3. PubMed ID: 18202595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting.
    Manosuthi W; Chaovavanich A; Tansuphaswadikul S; Prasithsirikul W; Inthong Y; Chottanapund S; Sittibusaya C; Moolasart V; Termvises P; Sungkanuparph S
    J Infect; 2007 Nov; 55(5):464-9. PubMed ID: 17714788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JD.
    Kirk O; Gatell JM; Mocroft A; Pedersen C; Proenca R; Brettle RP; Barton SE; Sudre P; Phillips AN
    Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):865-72. PubMed ID: 10988097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-PGL-Tb1 responses as an indicator of the immune restoration syndrome in HIV-TB patients.
    Simonney N; Dewulf G; Herrmann JL; Gutierrez MC; Vicaut E; Boutron C; Leportier M; Lafaurie M; Abgrall S; Sereni D; Autran B; Carcelain G; Bourgarit A; Lagrange PH
    Tuberculosis (Edinb); 2008 Sep; 88(5):453-61. PubMed ID: 18495539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility and effectiveness of early initiation of combination antiretroviral therapy in HIV-infected infants in a government clinic of Kwazulu-Natal, South Africa.
    Purchase SE; Van der Linden DJ; McKerrow NH
    J Trop Pediatr; 2012 Apr; 58(2):114-9. PubMed ID: 21705764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort.
    Grabar S; Tattevin P; Selinger-Leneman H; de La Blanchardiere A; de Truchis P; Rabaud C; Rey D; Daneluzzi V; Ferret S; Lascaux AS; Hanslik T; Costagliola D; Launay O;
    Clin Infect Dis; 2015 Apr; 60(8):1269-77. PubMed ID: 25601456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for 'unmasking immune reconstitution inflammatory syndrome' presentation of tuberculosis following combination antiretroviral therapy initiation in HIV-infected patients.
    Valin N; Pacanowski J; Denoeud L; Lacombe K; Lalande V; Fonquernie L; Girard PM; Meynard JL
    AIDS; 2010 Jun; 24(10):1519-25. PubMed ID: 20549841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complications of bacillus Calmette-Guérin immunization in children treated with highly-active antiretroviral therapy.
    Fernandes RC; Medina-Acosta E
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e361. PubMed ID: 20207181
    [No Abstract]   [Full Text] [Related]  

  • 30. European mitochondrial haplogroups are associated with CD4+ T cell recovery in HIV-infected patients on combination antiretroviral therapy.
    Guzmán-Fulgencio M; Berenguer J; Micheloud D; Fernández-Rodríguez A; García-Álvarez M; Jiménez-Sousa MA; Bellón JM; Campos Y; Cosín J; Aldámiz-Echevarría T; Catalán P; López JC; Resino S
    J Antimicrob Chemother; 2013 Oct; 68(10):2349-57. PubMed ID: 23749950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and risk factors of immune reconstitution inflammatory syndrome in HIV-TB coinfected patients.
    Dibyendu D; Sarkar RN; Phaujdar S; Bhattacharyya K; Pal HK
    Braz J Infect Dis; 2011; 15(6):553-9. PubMed ID: 22218514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics, incidence, and risk factors of HIV-related Hodgkin lymphoma in the era of combination antiretroviral therapy.
    Gotti D; Danesi M; Calabresi A; Ferraresi A; Albini L; Donato F; Castelli F; Scalzini A; Quiros-Roldan E;
    AIDS Patient Care STDS; 2013 May; 27(5):259-65. PubMed ID: 23600703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study.
    Mocroft A; Phillips AN; Gatell J; Ledergerber B; Fisher M; Clumeck N; Losso M; Lazzarin A; Fatkenheuer G; Lundgren JD;
    Lancet; 2007 Aug; 370(9585):407-13. PubMed ID: 17659333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome.
    Chang CC; Dorasamy AA; Gosnell BI; Elliott JH; Spelman T; Omarjee S; Naranbhai V; Coovadia Y; Ndung'u T; Moosa MY; Lewin SR; French MA
    AIDS; 2013 Aug; 27(13):2089-99. PubMed ID: 23525034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiretroviral therapy in a thousand patients with AIDS in Haiti.
    Severe P; Leger P; Charles M; Noel F; Bonhomme G; Bois G; George E; Kenel-Pierre S; Wright PF; Gulick R; Johnson WD; Pape JW; Fitzgerald DW
    N Engl J Med; 2005 Dec; 353(22):2325-34. PubMed ID: 16319381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low incidence of the immune reconstitution inflammatory syndrome among HIV-infected patients starting antiretroviral therapy in Gabon: a prospective cohort study.
    Janssen S; Osbak K; Holman R; Hermans S; Moekotte A; Knap M; Rossatanga E; Massinga-Loembe M; Alabi A; Adegnika A; Meenken C; van Vugt M; Kremsner PG; Meintjes G; van der Poll T; Grobusch MP
    Infection; 2017 Oct; 45(5):669-676. PubMed ID: 28349491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early development of immune reconstitution inflammatory syndrome related to Pneumocystis pneumonia after antiretroviral therapy.
    Mok HP; Hart E; Venkatesan P
    Int J STD AIDS; 2014 Apr; 25(5):373-7. PubMed ID: 24122663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
    Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
    J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment.
    Lapadula G; Cozzi-Lepri A; Marchetti G; Antinori A; Chiodera A; Nicastri E; Parruti G; Galli M; Gori A; Monforte Ad;
    AIDS; 2013 Mar; 27(5):769-79. PubMed ID: 23719349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.